Hims Hers Health, Inc. (“Hims Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will participate in Citi’s 2021 Healthcare Services, Medtech, Tools HCIT Virtual Conference, including a fireside chat presentation with CEO and Co-Founder, Andrew Dudum, on Thursday, February 25, 2021 at 3:20 p.m. E.T. Detailed Estimate. MarketBeat's community ratings are surveys of what our community members think about Hims & Hers Health and other stocks. HIMS Buy or Sell? I break down the latest Hims slide deck. MarketBeat just released five new trading ideas, but Hims & Hers Health wasn't one of them. Terms of Use and Privacy Policy. And as for this year, the forecast … 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Analyst projections state that HIMS is forecast to be at a low of $20 and a high of $23. Close price at the end of the last trading day (Wednesday, 3rd Mar 2021) of the HIMS stock was $15.02. Get a free HIMS technical analysis report to make a better HIMS stock predictions on how the stock will perform in the near future. This company is new to the stock market, but has huge potential. View all of HIMS's competitors. View Hims & Hers Health's Short Interest. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. View analysts' price targets for Hims & Hers Health or view top-rated stocks among Wall Street analysts. Identify stocks that meet your criteria using seven unique stock screeners. Hims & Hers Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HIMS.". Considering analysts have assigned the stock a price target range of $20-$23 as the low and high respectively, we find the trailing 12-month average consensus price target to be $21.5. Learn everything you need to know about successful options trading with this three-part video course. We got an inside look at the founder's journey, including why he chose a SPAC and the challenges he faced. Find market predictions, HIMS financials and market news. According to analysts' consensus price target of $19.67, Hims & Hers Health has a forecasted upside of 44.8% from its current price of $13.58. 4 analysts have issued twelve-month target prices for Hims & Hers Health's shares. Hims & Hers Health Inc - Class A Stock Price Forecast, "HIMS" Predictons for2021 Hims & Hers Health Inc. (NYSE: HIMS) is 53.84% higher on its value in year-to-date trading and has touched a low of $9.40 and a high of $25.40 in the current 52-week trading range. ), Hims & Hers Health has received 3 “underperform” votes. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Hims & Hers Health, Inc. (NYSE:HIMS)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 2.34. A rank of 50 means that 50% of stocks appear more favorable to our system. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. Predictions of HIMS stock price for tomorrow. Their forecasts range from $16.00 to $23.00. Get daily stock ideas top-performing Wall Street analysts. Hims & Hers Health is scheduled to release its next quarterly earnings announcement on Thursday, March 18th 2021. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Hims & Hers Health does not currently pay a dividend. Get the latest Hims & Hers Health, Inc. HIMS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View which stocks are hot on social media with MarketBeat's trending stocks report. WARNING: Trend forecast is still in the development phase and should be used with caution. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last twelve months. See what's happening in the market right now with MarketBeat's real-time news feed. The consensus among Wall Street research analysts is that investors should "buy" Hims & Hers Health stock. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Find the latest Hims & Hers Health, Inc. (HIMS) stock quote, history, news and other vital information to help you with your stock trading and investing. Hims & Hers Health Inc. (HIMS) shares on Thursday’s trading session, jumped 1.89 percent to see the stock exchange hands at $22.16 per unit. Hims, Inc. manufactures men's wellness products. Export data to Excel for your own analysis. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. View Hims & Hers Health, Inc. HIMS investment & stock information. This suggests a possible upside of 44.8% from the stock's current price. Given the current short-term trend, the stock is expected to rise 22.41% during the next 3 months and, with a 90% probability hold a price between $15.98 and $31.92 at the end of this 3-month period. liable for your own investment decisions and agree to 3 Wall Street analysts have issued ratings and price targets for Hims & Hers Health in the last 12 months. Please read the full disclaimer here. Hims & Hers Health, Inc is primarely in the business of services-offices & clinics of doctors of medicine. To hit the forecast high, the stock’s price needs a +77.33% upsurge from its current level, while the stock would need to tank 54.2% for it to hit the projected low. The company can be reached via phone at 800-368-0038. Hims & Hers Health Inc - Class A (HIMS) stock price prediction is 49.526728 USD. The HIMS-WS stock forecast is 61.864777 USD for 2022 March 07, Monday with technical analysis. Compare Top Brokerages Here. The HIMS stock forecast is provided by MarketClub with their Trade Triangle system.. HIMS Stock Predictions The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. S&P 500 3,841.94 Hims & Hers Health Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Want to start investing in real estate but don’t have the tens of thousands needed to get started? To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Find real-time HIMS - Hims & Hers Health Inc stock quotes, company profile, news and forecasts from CNN Business. After the deal closes, Hims’ stock will be traded on the New York Stock Exchange under the ticker “HIMS.” The combined company will be valued at roughly $1.6 billion. View analyst ratings for Hims & Hers Health or view top-rated stocks. Some companies that are related to Hims & Hers Health include PZ Cussons (PZC), MAV Beauty Brands (MAV), Accrol Group (ACRL), Warpaint London (W7L), DeepVerge (DVRG), Dogness (International) (DOGZ), DeepVerge plc (SKIN.L) (SKIN), Brand Architekts Group (BAR), Orchids Paper Products (TIS), Asaleo Care (AHY), Beiersdorf Aktiengesellschaft (BDRFY), Beiersdorf Aktiengesellschaft (BDRFF), Biologix Hair (BLGX), Bod Australia (BDA) and BWX Limited (BWX.AX) (BWX). The Hims & Hers Health Inc - Class A stock forecast is 49.526728 USD for 2022 March 08, Tuesday; and 325.790 USD for 2026 March 08, Sunday with technical analysis. Fundamental company data provided by Zacks Investment Research. As of February 12th, there was short interest totaling 2,600,000 shares, an increase of 165.5% from the January 28th total of 979,200 shares.